Results 41 to 50 of about 464,776 (390)

Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.

European Heart Journal, 2019
Persistence or recurrence of angina after a percutaneous coronary intervention (PCI) may affect about 20-40% of patients during short-medium-term follow-up.
F. Crea, C. B. Bairey Merz, J. Beltrame, C. Berry, P. Camici, J. Kaski, P. Ong, C. Pepine, U. Sechtem, H. Shimokawa   +9 more
semanticscholar   +1 more source

Limitations of adjustment for reporting tendency in observational studies of stress and self reported coronary heart disease [PDF]

, 2002
Recently, observational evidence has been suggested to show a causal association between various "psychosocial" exposures, including psychological stress, and heart disease. Much of this evidence derives from studies in which a self reported psychosocial
Carroll, D., Davey Smith, G., Hart, C., Heslop, P., Macleod, J., Metcalfe, C.   +5 more
core   +2 more sources

Biomarkers in acute coronary syndromes and their role in diabetic patients [PDF]

, 2005
Diabetic patients with acute coronary syndromes are at high risk for cardiovascular complications but risk stratification in these patients remains challenging.
Christopher Heeschen, Heeschen C, James SK, Khaliq A, Luttun A, Mak KH   +5 more
core   +1 more source

Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris

Circulation, 2018
In recent years, it has become apparent that coronary microvascular dysfunction plays a pivotal pathogenic role in angina pectoris. Functional and structural mechanisms can affect the physiological function of the coronary microvasculature and lead to ...
J. Kaski, F. Crea, B. Gersh, P. Camici
semanticscholar   +1 more source

METABOLIC MYOCARDIAL CYTOPROTECTORS IN THERAPY OF STABLE ISCHEMIC HEART DISEASE: EVIDENCE OF EFFECTIVENESS AND USE RECOMMENDATIONS

Медицинский совет, 2017
The review describes mechanisms of action of metabolic myocardial cytoprotectors and recommendations on their use within the pharmacotherapy of stable ischemic heart disease.
N. B. Perepech
doaj   +1 more source

Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the international observational CLARIFY registry [PDF]

, 2014
Importance: In the era of widespread revascularization and effective antianginals, the prevalence and prognostic effect of anginal symptoms and myocardial ischemia among patients with stable coronary artery disease (CAD) are unknown.<p></p>
Al-Zaibag, Muayed, Dorian, Paul, Ferrari, Roberto, Ford, Ian, Fox, Kim M., Greenlaw, Nicola, Hu, Dayi, Shalnova, Svetlana, Sokn, Fernando José, Steg, Philippe Gabriel, Tardif, Jean-Claude, Tendera, Michal   +11 more
core   +1 more source

Heart or Mind? Unexplained chest pain in patients with and without coronary disease

Heart and Mind, 2018
Patients with unexplained chest pain continue to present a difficult challenge for clinicians, especially for cardiologists. Approximately 20% of patients undergoing diagnostic coronary arteriography for acute or chronic cardiac ischemia have ...
Dina Garroni, Gabriele Fragasso
doaj   +1 more source

Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. [PDF]

, 2018
BACKGROUND: Although coronary computed tomographic angiography (CTA) improves diagnostic certainty in the assessment of patients with stable chest pain, its effect on 5-year clinical outcomes is unknown.
Adamson, Philip D., Berry, Colin, Boon, Nicholas A., Boylan, Heather, Brown, Ammani, Connolly, Eugene, Dweck, Marc R., Farrell, Lesley, Flather, Marcus, Forbes, John, Frood, Alison, Glover, Caroline, Hunter, Amanda, Johnstone, Janet, Lanaghan, Kirsten, Lewis, Stephanie, MacLean, Scott, Mangion, Kenneth, McGlynn, Deborah, McGregor, Lorraine, McLennan, Evonne, Mills, Nicholas L., Mordi, Ify, Murdoch, Laura, Newby, David E., Norrie, John, Paterson, Victoria, Roditi, Giles, Shah, Anoop S.V., Steedman, Tracey, Teenan, Marion, Teyhan, Fiona, The SCOT-HEART Investigators,, Timmis, Adam D., Tzemos, Nikolaos, van Beek, Edwin J.R., Williams, Michelle C., Woodward, Rosie   +37 more
core   +7 more sources

Ivabradine: An Intelligent Drug for the Treatment of Ischemic Heart Disease

Molecules, 2012
Heart rate (HR) is a precisely regulated variable, which plays a critical role in health and disease. Elevated resting HR is a significant predictor of all-cause and cardiovascular mortality in the general population and patients with cardiovascular ...
Graziano Riccioni
doaj   +1 more source

Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN‐CTO Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Given that percutaneous coronary intervention (PCI) of a chronic total occlusion (CTO) is indicated primarily for symptom relief, identifying patients most likely to benefit is critically important for patient selection and shared decision ...
Neel M. Butala, Hector Tamez, Eric A. Secemsky, J. Aaron Grantham, John A. Spertus, David J. Cohen, Philip Jones, Adam C. Salisbury, Suzanne V. Arnold, Frank Harrell, William Lombardi, Dimitrios Karmpaliotis, Jeffrey Moses, James Sapontis, Robert W. Yeh   +14 more
doaj   +1 more source